1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
OS Therapies Incorporated

OS Therapies Incorporated

OSTX
OS Therapies IncorporatedUS flagNew York Stock Exchange American
1.56
USD
+0.05
- -
69.48MMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
5
4
4
7
29
+ Selling, General & Admin
2
1
1
4
12
+ Research & Development
2
3
3
3
16
+ Other Operating Expense
1
- -
- -
- -
- -
Operating Income (Loss)
-5
-4
-4
-7
-29
- Non-Operating (Income) Loss
3
2
3
2
- -
+ Interest Expense, Net
3
2
3
2
- -
+ Interest Expense
3
2
3
2
- -
- Interest Income
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
Pretax Income
-7
-6
-8
-9
-29
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-7
-6
-8
-9
-29
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-7
-6
-8
-9
-29
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-7
-6
-8
-9
-29
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-8
-6
-8
-9
-29
EBIT
-5
-4
-4
-7
-29
EBITDA
-5
-4
-4
-7
-28
EBITDA Margin (%)
- -
- -
- -
- -
- -
EBITA
-5
-4
-4
-7
-29
Gross Margin (%)
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
23
20
21
7
29
Basic EPS, GAAP
-0.33
-0.32
-0.38
-1.28
-0.98
Basic EPS from Cont Ops
-0.32
-0.31
-0.38
-1.28
-0.98
Diluted Weighted Avg Shares
23
20
21
7
29
Diluted EPS, GAAP
-0.33
-0.32
-0.38
-1.28
-0.98
Diluted EPS from Cont Ops
-0.32
-0.31
-0.38
-1.28
-0.98

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
1
6
- -
+ Cash, Cash Equivalents & STI
- -
- -
- -
6
- -
+ Cash & Cash Equivalents
- -
- -
- -
6
- -
+ ST Investments
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
7
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
7
+ Total Intangible Assets
- -
- -
- -
- -
7
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
7
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
Total Assets
- -
1
1
6
7
+ Payables & Accruals
2
3
5
3
12
+ Accounts Payable
1
1
3
2
10
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
3
1
2
+ ST Debt
- -
- -
15
- -
- -
+ ST Borrowings
- -
- -
15
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
+ Other ST Liabilities
2
3
5
2
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
2
3
5
2
- -
Total Current Liabilities
3
6
25
5
12
+ LT Debt
7
10
- -
- -
- -
+ LT Borrowings
7
10
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
+ Other LT Liabilities
1
2
- -
4
1
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
1
1
- -
4
1
Total Noncurrent Liabilities
8
12
- -
4
1
Total Liabilities
12
18
25
9
13
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
4
6
35
61
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
4
5
35
61
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-15
-22
-30
-38
-67
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-11
-18
-24
-3
-6
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-11
-18
-24
-3
-6
Total Liabilities & Equity
- -
1
1
6
7
Shares Outstanding
21
21
21
21
37
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
Net Debt
7
10
15
-6
- -
Net Debt to Equity
-61.06
-57.96
-60.67
169.4
4.43
Tangible Common Equity Ratio
-3,514.22
-3,448.9
-3,009.4
-58.98
-3,756.62
Current Ratio
0.09
0.08
0.03
1.2
0.03
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-7
-6
-8
-9
-29
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
2
2
3
2
5
+ Stock-Based Compensation
- -
- -
- -
- -
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
2
3
1
- -
+ Chg in Non-Cash Work Cap
1
1
2
- -
9
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
1
2
- -
9
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-4
-3
-7
-14
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
5
8
+ Increase in Capital Stock
- -
- -
- -
5
8
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
3
4
3
2
- -
+ Cash From Debt
3
4
3
2
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
6
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
3
4
3
13
9
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
-1
- -
- -
5
-5
EBITDA
-5
-4
-4
-7
-28
EBITDA Margin (%)
- -
- -
- -
- -
- -
Free Cash Flow
-4
-4
-3
-7
-15
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
- -
-6
-14
Free Cash Flow per Basic Share
-0.19
-0.19
-0.15
-1.05
-0.5
Price/Free Cash Flow
- -
- -
- -
-4.08
-2.97
Cash Flow to Net Income
0.59
0.61
0.39
0.82
0.5
Capital Expenditures
- -
- -
- -
- -
- -